Immobilized HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer[Biotin], His & Avi, Human, His Tag at 0.5 μg/ml (100 μl/Well) on streptavidin(5 μl/ml) precoated plate. Dose response curve for Anti-B2M Antibody, mFc Tag with the EC50 of 7.7 ng/ml determined by ELISA.
The purity of HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.
HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer[Biotin], His & Avi, Human on Bis-Tris PAGE under Non reducing (N) condition. The purity is greater than 95%.
HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer[Biotin], His & Avi, Human
HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules performed by cytotoxic lymphocytes.
| Z06512 | |
|
|
|
| ￥14800 | |
|
|
|
|
|
|
| 联系我们 | |
